Judge Steps Aside from Black-Market HIV Drug Case After Surprise Stock Buy Sparks Conflict Concerns
A high-stakes case over counterfeit HIV medications has taken an unexpected turn: the federal judge overseeing it has removed herself after learning her own brokerage account briefly held shares of Gilead Sciences, the pharmaceutical company at the center of the case. Judge Mary Kay Vyskocil, based in Manhattan, disclosed that her financial advisor—without her knowledge—purchased …











